Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study is conducted in Europe. The aim of this study is to demonstrate the clinical effectiveness and safety of liraglutide and dipeptidyl peptidase-4 (DPP-4) inhibitor therapy in routine primary care in Europe.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
952 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal